Altimmune ALT
NASDAQ ALT
$2.23 -0.07 (-3.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019)

Updated

Altimmune's Long-Term Debt Repayments came in at $632,000 for FY2020, up 116.4% from $292,002 in FY2019.

Analysis

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019) Analysis & Trends

Going back to FY2010, Altimmune's Long-Term Debt Repayments data covers 6 years.

  • Long-Term Debt Repayments carries a four-year compound annual growth rate of 67.1% (FY2016 to FY2020).
  • The five-year range for annual Long-Term Debt Repayments is $81,098 (FY2016) to $1.55 million (FY2018).
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $292,002 in FY2019 (-81.2%), $1.55 million in FY2018 (+629.5%), $212,431 in FY2017 (+161.9%) and $81,098 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Altimmune 411.69 Mn -730.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 105,062.00
Sep 30, 2019 30,795.00
Dec 31, 2016 80,999.00
API Access

Altimmune Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ALT&period=max&api_key=YOUR_API_KEY